With their unique Aeonian Rating® selection tool, they revolutionise the market place of research-use-only antibodies by unbiased ranking, ensuring the requirements of scientists are better met and the suppliers can more accurately target their offerings according to demand.

Contact information

Other startups & participants

AromAB
AromAb is developing a new technology to purify antibodies for biological drugs more quickly and che...
Aziflu
Aziflu is developing new antiviral drugs against influenza (flu). Their focus is on treatments that ...
CaraOmics
CaraOmics is developing a platform for building “clinical digital twins”: digital models of patients...
Omivera
Omivera is developing a platform called CellEKT that allows pharmaceutical researchers to better mea...
Gateway Bio
Gateway Bio is a biotech startup that aims to address antibiotic resistance with a new type of drug ...
QDiaMon
QDiaMon is a healthtech startup developing a wearable device that can measure multiple biomarkers fr...
HeartSmart
HeartSmart is a biotech startup developing a human heart tissue model to improve heart failure drug ...
Radigene
Radigene develops a novel imaging technology that makes therapeutic cells visible inside the body. B...
ONEIRA
Oneira is a biotech startup working to improve cancer treatments by being able to better direct ther...
Vindi Biosystems
Vindi Biosystems is developing a wearable device for continuous, real-time monitoring of disease ass...
SBMatrices
SBMatrices is making a synthetic, animal-free gel with Fybrix in which you can grow cells for resear...
GlycoDiagnostics
GlycoDiagnostics aims to detect people with potentially dangerous liver disease early on, before it ...